YORBA LINDA, Calif. (PRWEB) September 26, 2018
Infiltrating myeloid cells constitute a significant component of the suppressive tumor microenvironment (TME) and possibly contribute to therapeutic failures. An understanding of the immune regulatory context of the TME is required to harness the power of the antitumor immune response. In this webinar, which is sponsored by Cell Signaling Technology, attendees will learn of new solutions to better understand the TME in a context-dependent manner.
Using highly validated antibodies, immunohistochemical (IHC) techniques were employed in a 7-color TSA-based multiplex panel along with single- and dual-plex chromogenic stains to visualize biomarker expression in an array of tumor types. Newly validated Arginase1 and IDO1 monoclonal antibodies add a functional readout of the immunosuppressive TME to phenotypic marker analysis.
The speaker for this event will be Christopher Grange, an IHC specialist with Cell Signaling Technology. Grange has nearly 10 years of experience working with a variety of IHC techniques and technologies. His main focus over this time has been the development and validation of IHC-grade antibodies in a number of research areas. The main area of focus has been immuno-oncology, where he has developed automated IHC assays for novel I/O targets and provided support for multiple preclinical programs.
LabRoots will host the webinar on October 3, 2018, beginning at 9 a.m. PDT, noon EDT. To learn more about this event, discover the continuing education credits offered, or to register for free, click here.
About Cell Signaling Technology
Cell Signaling Technology is a private, family owned company, founded by scientists and dedicated to providing high-quality research tools to the biomedical research community. The company’s employees operate worldwide from its US headquarters in Massachusetts and offices in the Netherlands, China, and Japan.
LabRoots is the leading scientific social networking website, which provides daily scientific trending news, as well as produces educational virtual events and webinars, on the latest discoveries and advancements in science. Contributing to the advancement of science through content sharing capabilities, LabRoots is a powerful advocate in amplifying global networks and communities. Founded in 2008, LabRoots emphasizes digital innovation in scientific collaboration and learning, and is a primary source for current scientific news, webinars, virtual conferences, and more. LabRoots has grown into the world’s largest series of virtual events within the Life Sciences and Clinical Diagnostics community.